Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01591616 · ClinicalTrials.gov registry record · Phase 4
Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel
A Phase 4 study, sponsored by Dentsply International.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT01591616 is a Phase 4 study that has completed, run by Dentsply International. The registered enrollment target is 16 participants.
The verdict
NCT01591616, a Phase 4 study, has completed, sponsored by Dentsply International.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
To establish Oraqix is safe when used on adolescent volunteers.
Interventions
- DRUG lidocaine and prilocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01591616
The ClinicalTrials.gov registry entry for NCT01591616 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dentsply International, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lidocaine and prilocaine is the first listed.
NCT01591616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01591616 about?
NCT01591616 is a clinical study titled "Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel". To establish Oraqix is safe when used on adolescent volunteers.
What is the current status of trial NCT01591616?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2010-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01591616?
The interventions under investigation include: lidocaine and prilocaine (DRUG).
Who is sponsoring clinical trial NCT01591616?
This trial is sponsored by Dentsply International, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.